Alliancebernstein L.P. Wave Life Sciences Ltd. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Alliancebernstein L.P. holds 58,070 shares of WVE stock, worth $749,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,070

Previous 403,984 85.63%

Holding current value

$749,103

Previous $2.02 Million 76.38%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.12 - $9.01 $1.77 Million - $3.12 Million	-345,914 Reduced 85.63%	58,070 $476,000
Q2 2024 Aug 14, 2024	BUY	$4.38 - $6.48 $295,190 - $436,719	67,395 Added 20.02%	403,984 $2.02 Million
Q1 2024 May 14, 2024	BUY	$3.54 - $6.84 $1.15 Million - $2.22 Million	324,689 Added 2728.48%	336,589 $2.08 Million
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $49,504 - $81,753	11,900 New	11,900 $60,000
Q2 2022 Aug 15, 2022	SELL	$1.23 - $3.25 $41,697 - $110,175	-33,900 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.0 - $3.28 $4,000 - $6,560	-2,000 Reduced 5.57%	33,900 $68,000
Q4 2021 Feb 14, 2022	SELL	$3.14 - $5.15 $15,072 - $24,720	-4,800 Reduced 11.79%	35,900 $113,000
Q2 2021 Jul 30, 2021	BUY	$5.65 - $7.47 $31,075 - $41,085	5,500 Added 15.63%	40,700 $271,000
Q1 2021 May 06, 2021	SELL	$5.61 - $12.01 $30,294 - $64,854	-5,400 Reduced 13.3%	35,200 $197,000
Q3 2020 Nov 12, 2020	SELL	$8.49 - $19.54 $61,977 - $142,642	-7,300 Reduced 15.24%	40,600 $345,000
Q2 2020 Aug 13, 2020	BUY	$7.44 - $11.29 $74,400 - $112,899	10,000 Added 26.39%	47,900 $499,000
Q1 2020 May 14, 2020	BUY	$6.94 - $14.22 $95,078 - $194,814	13,700 Added 56.61%	37,900 $355,000
Q3 2019 Nov 14, 2019	BUY	$19.17 - $27.4 $46,008 - $65,760	2,400 Added 11.01%	24,200 $497,000
Q1 2019 May 14, 2019	BUY	$32.69 - $47.91 $124,221 - $182,058	3,800 Added 21.11%	21,800 $847,000
Q4 2018 Feb 13, 2019	SELL	$37.1 - $50.11 $25,970 - $35,077	-700 Reduced 3.74%	18,000 $757,000
Q2 2018 Aug 13, 2018	BUY	$33.85 - $50.65 $132,015 - $197,535	3,900 Added 26.35%	18,700 $715,000
Q1 2018 May 14, 2018	BUY	$32.45 - $54.7 $45,430 - $76,580	1,400 Added 10.45%	14,800 $593,000
Q4 2017 Feb 13, 2018	BUY	$21.8 - $39.35 $15,260 - $27,545	700 Added 5.51%	13,400 $470,000
Q3 2017 Nov 13, 2017	BUY	$16.4 - $25.05 $208,279 - $318,135	12,700	12,700 $276,000

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.12B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Wave Life Sciences Ltd. Transaction History